Renaissance Capital logo

Evogene

Priced, NYSE: EVGN

Develops genetically enhanced seeds to elevate crop performance and productivity.

Industry: Health Care

First Day Return: +16.8%

Develops genetically enhanced seeds to elevate crop performance and productivity.
IPO Data
IPO Date 11/20/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $74
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Rehovot, Israel
Founded 2000
Employees at IPO 188
Website www.evogene.com

Evogene (EVGN) Performance

EVGN vs. IPO Index (IPOUSA)